SRL
IOVA icon

Scientech Research LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Scientech Research LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Sell
65,757
-72,391
-52% -$275K 0.22% 125
2026
Q1 		$485K Sell
138,148
-73,329
-35% -$235K 0.4% 54
2025
Q4 		$577K Buy
+211,477
New +$489K 0.36% 62
2025
Q2 		– Sell
-69,881
Closed -$233K – 711
2025
Q1 		$233K Buy
+69,881
New +$360K 0.06% 470
2024
Q4 		– Sell
-17,484
Closed -$164K – 713
2024
Q3 		$164K Buy
+17,484
New +$166K 0.03% 564
2024
Q2 		– Sell
-11,106
Closed -$165K – 654
2024
Q1 		$165K Buy
+11,106
New +$129K 0.09% 375

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Scientech Research LLC's IOVA Position: Q2 2026 in Review

Scientech Research LLC reduced its Iovance Biotherapeutics (IOVA) stake by 52% in Q2 2026, selling an estimated $275K and leaving 65,757 shares worth $274K. The position accounts for 0.22% of the portfolio, ranked #125.

Scientech Research LLC first reported a position in IOVA in Q1 2024 and has held it in 6 quarters since. The position peaked at $577K in Q4 2025. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Scientech Research LLC held 65,757 shares of Iovance Biotherapeutics worth $274K as of Q2 2026.
  • Scientech Research LLC sold 72,391 Iovance Biotherapeutics shares in Q2 2026, an estimated $275K.
  • Iovance Biotherapeutics made up 0.22% of Scientech Research LLC's portfolio in Q2 2026, its #125 holding.
  • Scientech Research LLC first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 6 quarters since.
  • Scientech Research LLC's Iovance Biotherapeutics position peaked at $577K in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.